Production (Stage)
Carisma Therapeutics, Inc.
CARM
$0.448
$0.01834.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -85.21% | -76.01% | -70.12% | -64.20% | -58.22% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -66.16% | -15.42% | -85.30% | -85.85% | -61.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 503.37% | 13.60% | -- | -- | -- |
| Total Current Assets | -77.11% | -70.39% | -65.01% | -58.49% | -57.82% |
|
|
|||||
| Total Current Assets | -77.11% | -70.39% | -65.01% | -58.49% | -57.82% |
| Net Property, Plant & Equipment | -84.26% | -28.11% | -14.71% | -20.32% | 9.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 42.47% | 18.18% | -19.32% | 373.33% |
| Total Assets | -78.38% | -65.99% | -60.61% | -55.39% | -52.74% |
|
|
|||||
| Total Accounts Payable | 50.09% | -47.09% | -28.27% | -18.25% | -53.06% |
| Total Accrued Expenses | -0.51% | -2.79% | -35.35% | -3.88% | -53.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -57.61% | -10.23% | 77.23% | -33.48% | 2.09% |
| Total Finance Division Other Current Liabilities | -64.19% | 101.39% | -14.10% | -13.36% | -17.61% |
| Total Other Current Liabilities | -64.19% | 101.39% | -14.10% | -13.36% | -17.61% |
| Total Current Liabilities | -20.50% | 0.92% | -18.48% | -13.11% | -38.81% |
|
|
|||||
| Total Current Liabilities | -20.50% | 0.92% | -18.48% | -13.11% | -38.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -81.06% | -37.37% | -36.94% | -15.01% | 114.93% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -10.08% | -9.49% | -9.54% | -10.13% | -1.63% |
| Total Liabilities | -16.35% | -7.39% | -12.07% | -11.05% | -10.22% |
|
|
|||||
| Common Stock & APIC | 1.17% | 2.22% | 2.50% | 2.39% | 2.30% |
| Retained Earnings | -19.22% | -24.67% | -28.46% | -35.76% | -44.41% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -436.50% | -205.19% | -124.03% | -99.46% | -87.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -436.50% | -205.19% | -124.03% | -99.46% | -87.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -436.50% | -205.19% | -124.03% | -99.46% | -87.34% |
|
|
|||||